Robert Hettle

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Early Breast Cancer

Combination Therapy

Systematic Review

Top Venues

PharmacoEconomics - open

Future oncology (London, England)

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Polyzoi, Mattias Ekman, Anja Reithmeier, Johanna Jacob, Emma Karlsson, Evelina Bertranou, Barbro Linderholm, Robert Hettle
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden. PharmacoEconomics - open (2023)
Robert Hettle, Adela Mihai, Shona Helen Lang, Sophie Tatman, Stephanie Louise Swift
Real-world outcomes for first line next-generation hormonal agents in metastatic prostate cancer: a systematic review. Future oncology (London, England) (2023)
David Shao Peng Tan, Jack Junjie Chan, Robert Hettle, Wrik Ghosh, Amrita Viswambaram, Cindy Chen Yu
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore. Journal of gynecologic oncology 32 (2) (2021)